FTFinancial Times·1hBusiness
score+0.00
FirstFT: AstraZeneca and Bristol Myers Squibb discuss $400bn tie-up
Original
FirstFT: AstraZeneca and Bristol Myers Squibb discuss $400bn tie-up
“The headline uses factual, financial terminology to report on merger discussions without implying success or failure.”